Inhibitors of PD-1 in Non-Small Cell Lung Cancer: A Meta-Analysis of Clinical and Molecular Features

OBJECTIVE: PD-1 inhibitors have become an indispensable treatment in Non-Small Cell Lung Cancer (NSCLC), but the potential predictive value of clinical and molecular features need to be clarified. The objective of the study was to study the potency of PD-1 inhibitors in patients with NSCLC in contex...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Gengwei, Liu, Wenjie, Chen, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037098/
https://www.ncbi.nlm.nih.gov/pubmed/35479081
http://dx.doi.org/10.3389/fimmu.2022.875093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037098/
https://www.ncbi.nlm.nih.gov/pubmed/35479081
http://dx.doi.org/10.3389/fimmu.2022.875093

Ejemplares similares